MPIP has developed several publications highlighting “best practices” gathered from our research and ongoing dialogue with medical journal editors, industry experts, authors, and other interested parties regarding ways to continue to improve transparency in reporting the results of industry-sponsored research.
We emailed a survey to experienced medical editors to evaluate the degree of change observed in transparency and credibility of industry-sponsored clinical trial publications over a 5-year period beginning in 2010 and ending in 2015. We report the assessment of 293 editor responses on the impact of best practices on transparency plus the importance of MPIP’s “Ten Recommendations” (2012) on publication credibility and perceived degree of adoption of these recommendations.
Transparency and Credibility of Industry-Sponsored Clinical Trial Publications: A Survey of Journal Editors. Mooney LA, Fay L, DeCastro B, Zanki TA, Mansi B. Curr Med Res Opin. 2019;35(7):1221-1230.
We conducted qualitative research among interested parties involved in reporting adverse events in clinical trial publications to identify key areas for improvement and collaborated with journal editors and industry experts to codify best practice recommendations to facilitate clinically meaningful adverse event reporting in clinical trial publications to complement the CONSORT Harms Extension.
Recommendations to Improve Adverse Event Reporting in Clinical Trial Publications: A Joint Pharmaceutical Industry/Journal Editor Perspective. Lineberry N, Berlin JA, Mansi B, et al. BMJ. 2016;355:i5078.
In collaboration with academic researchers, we conducted a novel attitude study to identify ambiguities in authorship disclosures encountered in industry-sponsored publications not well addressed by current guidelines. Results from the study, which included close to 500 clinical investigators, journal editors, publication professionals, and medical writers, led to the development of a standardized approach to facilitate transparent and consistent authorship decision making.
Five-Step Authorship Framework to Improve Transparency in Disclosing Contributors to Industry-Sponsored Clinical Trial Publications. Marušić A, Hren D, Mansi B, et al. BMC Med. 2014;12:197.
We characterized the persistent and perceived credibility gap in reporting the results of industry-sponsored research and identified approaches to close the gap in our seminal recommendations stemming from our 2010 journal editor–pharma roundtable.
Ten Recommendations for Closing the Credibility Gap in Reporting Industry-Sponsored Clinical Research: A Joint Journal and Pharmaceutical Industry Perspective. Mansi BA, Clark J, David FS, et al. Mayo Clinic Proc. 2012;87(5):424-429.
We developed a compilation of best practices for manuscript preparation and submission, aimed at industry-sponsored clinical trials, as a result of our unique collaboration with journal editors during our 2009 journal–pharma roundtable in Vancouver, British Columbia.
Authors’ Submission Toolkit: A Practical Guide to Getting Your Research Published. Chipperfield L, Citrome L, Clark J, et al. Curr Med Res Opin. 2010;26(8):1967-1982.